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I. INTRODUCTION AND REVIEW OF LITERATURE 
 
 Approximately one half of the annual healthcare expenditure in the United States 
is due to tissue and organ failure 1.  Organs such as kidneys and heart as well as simple 
tissue such as skin or veins can be adversely affected by injury or disease to the point that 
their normal function is impeded.  Traditionally patients would resort to surgical repair, 
prosthetics, drug therapy, or transplants; each with its own set of drawbacks 2. Surgical 
repair is stressful and potentially dangerous to the patients and can require extended 
hospital stay as well as the need for follow up operations.  In case of prosthetics, although 
many improvements have been made in recent years, there are still the fundamental 
issues that exist when introducing foreign material into the human body.  Drug therapy 
can be successful in treating some diseases especially if the damage to the tissue or organ 
is not extensive; however there are unwanted side effects.   
 In many cases such as failed major organs the only viable option is a transplant 
from a donor.  The vast majority of patients in need of major organ transplants face long 
waiting lists.  According to the Organ Procurement and Transplantation Network there 
are currently over 88,000 patients on the waiting  list for organ transplants; of those over 
12,00 have been waiting for over 5 years 3.  Even after a transplant operation the patient 




 The difficulties associated with these treatment options have led scientists to 
pursue other alternatives to the general approach to the problem of damaged or diseased 
organs and tissues.  One such alternative is the field of tissue engineering.  
 
Tissue Engineering 
 “Tissue engineering is the application of principles and methods of engineering 
and life sciences toward fundamental understanding of structure-function relationships in 
normal and pathological substitutes to restore, maintain, or improve tissue functions.  In 
other words, tissue engineering involves the use of cells and extracelluar components, 
either synthetic or natural, to create replacement, implantable parts to restore, maintain, 
or repair the function of damaged or diseased tissue and organs”4.  The General approach 
to a specific application of engineered tissue involves first evaluating the conditions 
under which cells can produce tissue or organs.  The most common method is to 
construct a porous 3-D structure onto which cells can attach and proliferate, commonly 
refereed to as a tissue scaffold.  This tissue scaffold should be biocompatible, sterilizable, 
and poses high enough surface area and void volume to allow for cell growth and 
differentiation as well as nutrient supply and waste removal 5.  Ideally scaffolds should 
also be designed to degrade at specific rates as to allow for more space for the cells to 
grow into and eventually the scaffold is completely and harmlessly removed from the 
patient.  After the scaffold material has been prepared, cells are seeded onto the substrate 
and cultured in vitro for sometime, and finally the tissue scaffold is implanted at the 
necessary site in vivo (Figure 1).  This is the most common method used by researchers 
and has yielded commercially available skin.  Tissues such as bone, cartilage, blood 
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vessels, tendons, and others are also under investigation and have shown promise for 
success 2.  As the degree of complexity of the targeted tissue or organ increases, so do the 
required steps in the process.  For example, stem cells and various growth and 
differentiation hormones may be included in the scaffold to yield the desired type and 
texture of cells; while scaffold architecture and in vitro fluid flow might be used to obtain 
the required cell orientation.  As the science evolves, so will the methods used; however 









Figure 1 Conceptual process for tissue engineering. 
Scaffold Material  
 Since the tissue scaffold will mimic the function of the extracelluar matrix (ECM) 
the design principles in tissue scaffold material have been governed by the function of the 
ECM. Extracelluar matrix contributes greatly in signal transduction and provides a 
platform onto which cells can grow and repair in an injured site 6.  Any foreign material 
introduced to the body should above all be biocompatible and non-toxic. Furthermore, 
scaffolds should allow cell migration, adhesion, and proliferation; which inherently 
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requires a highly porous scaffold.  Porosity also allows nutrients to reach the cells and 
waste removed from them.  Previous research has shown that a porosity of at least 80-
85% is required for scaffold success.  
 Also of importance is the degradation rate and nature of the degraded by-
products. Since the goal is to completely remove the scaffold from the body the 
degradation process must be complete and obtained in a determined time frame. Ideally 
the degradation rate is synchronized with the rate of cell growth therefore not hindering 
the tissue regeneration process. The degradation products must also meet requirements 
for biocompatibility.  
 Another important factor in tissue scaffold design is the mechanical stresses that 
the scaffold must undergo at the implant site. Obviously various applications will require 
different mechanical strength properties; for example a blood vessel is under higher and 
more frequent stress than a portion of skin. Since the cells in the implant might not be 
able to mechanically support themselves for a period of time, the mechanical properties 
of the scaffold as it undergoes degradation is also critical. 
 The lack of suitable scaffold material has become a bottleneck in field of tissue 
engineering and is the subject of many research studies.  Polymeric materials are ideal 
candidates for tissue scaffolds since they can be degraded through hydrolysis or enzyme-
specific reaction in vivo 7.  Since a vast majority of biodegradable polymers do not satisfy 
all of the essential properties for a tissue scaffold material, numerous natural and 
synthetic polymers have been studied for tissue engineering scaffolds 8.  Examples of 
synthetic biopolymers include poly-lactic-acid (PLA), poly-glycolic-acid (PGA), and 
their co-polymer PLGA.  Some of the natural biodegradable polymers include gelatin, 
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fibrin, chitin and its partially or completely deacetylated derivative chitosan.  Most 
synthetic biodegradable polymers posses desirable mechanical strength and adjustable 
degradation rates but less than optimal cell compatibility while natural products such as 
collagen are inherently weak mechanically yet they exhibit excellent cell interactions 9.  
 
Chitosan as scaffold material  
 Chitosan, the deacetylated version of chitin, has gained much attention as a 












Figure 2 Chemical structure of chitosan. 
 
Chitosan (Figure 2) can form porous 3-D scaffolds through a controlled-rate 
freezing of chitosan solutions and subsequent lyophilization 12.  Ice crystals nucleate in 
solution during the freezing process and grow along the thermal gradients.  During this 
process chitosan falls out of solution and is trapped between the ice crystals forming a 
honeycomb structure.  At this time, if the solvent is allowed to melt it will re-dissolve the 
chitosan returning back to solution; therefore, lyophilization is used to remove the ice and 
creates a porous structure.  Since the pore size is directly related to the size of the ice 
crystals, the mean pore diameter can be controlled by the rate of freezing.  The 
orientation of the pores can also be controlled by directing the pathways of heat removal 
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during freezing (Figure 3).  Controlled rate freezing technique generates an open pore 
structure, suitable for guiding cell ingrowth.  Since Controlled rate freezing technique is 
carried out at low temperatures, it avoids the concern associated with the loss of 
biological activity of proteins due to thermal denaturation.  Bioactive molecules such as 
mitogenic factors and therapeutic molecules can be incorporated during the fabrication 
process without altering their biological regulation.   
 
 
Figure 3 Scaffold fabrication process. 
 Chitosan scaffolds support the attachment, morphology, and proliferation of 
various kinds of cells, including chondrocytes, dermal fibroblasts, hepatoctes, and adrenal 
chromaffin cells 4.  Chitosan biocompatibility has been investigated by implanting porous 
chitosan scaffolds in mice and evaluating the subsequent histology.  Results showed 
minimal inflammatory reaction to the chitosan scaffold 13.   
 Chitosan has been combined with various biopolymers.  Mao, et al. 14, 15 
combined chitosan with gelatin to construct an artificial skin bilayer.  While 
chitosan/calcium phosphate scaffolds have been used for bone regeneration 4.  Mixing 
chitosan with other biopolymers allows scientists to enhance its mechanical properties or 
cell-scaffold interactions.  
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 Along with ease of processing and good cellular support for various cell types, 
chitosan also possesses desirable wound healing properties, antimicrobial activity, and 
biodegradability.  Several clinical studies have shown that chitin-based products allow for 
faster healing of surgical wounds as well as reduced scaring.  Chitosan is considered a 
primer upon which normal tissue is organized.  Enhanced vascularization and a 
continuous supply of chitooligomers to the wound that enable the proper accumulation, 
assembly and orientation of collagen fibrils are properties exerted by chitosan in the 
rebuilding site 4.  Chitosan attacks the microbial cell wall which inhibits microbial 
activity.  Chitosan has been investigated as a possible mechanism to prevent secondary 
infections or to prevent immunological rejections of transplants or implants.   
 
Chitosan Biodegradation 
 As for any tissue scaffold candidate material, the degradation behavior of chitosan 
is of high importance.  Biodegradable and nontoxic materials which are capable of 
support cellular activity are highly desirable.  Various studies have shown that chitin and 
chitosan degrade in vivo via enzymatic hydrolysis by lysozyme.  Lysozyme can be found 
throughout the body; however, the degradation rate is a function of the type of chitin, 
deacetylation method, and local pH. 
 It has been shown that with other factors being equal heterogeneously prepared 
chitosans were less susceptible to hydrolysis by lysozyme than homogeneously prepared 
chitosans 16.  Data suggest that there must be segments consisting of at least three 
consecutive N-acetyl sugar residues for lysozyme to be effective.  These block segments 
are readily found in homogeneously prepared chitosans.  Pangburn et al  17 report that 
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pure chitin is most susceptible to lysozyme while pure chitosan which has been 100% 
deacetylated cannot be degraded by lysozyme.  It has been determined that the optimum 
pH for lysozyme to degrade chitosan is around 5.2 18. Varum et al 19  showed that the 
initial degradation rate of lysozyme was 5 times higher at a pH of 4.5 than 7. 
 In tissue engineering applications it is important to minimize the exposure time 
between the scaffold and the host in order to minimize adverse affects.  To utilize 
chitosan as a scaffold material its degradation rate must be maximized and controlled.  
While factors such as MW and the degree of deacetylation can be controlled prior to 
scaffold implantation, the pH of the implant site cannot. 
 Therefore, it is desirable to locally reduce and maintain the pH of the implant site 
without causing side effects to the patient.  The approach taken by the authors is to place 
a secondary polymer within the chitosan matrix that produces acidic byproducts during 
its own degradation.  Thus, by controlling the secondary polymer’s degradation rate we 
can control the pH in the chitosan scaffold and further increase and control chitosan’s 
degradation rate.  The requirements for this secondary polymer is that it will be 
biocompatible, proven safe for in vivo implantation, have tunable degradation rate, and 
degradation products are acidic but safe biocompatible components. 
 
PLGA 
 Poly-lactic-co-glycolic acid (PLGA) was chosen to be the polymer to be added 
into the chitosan matrix.  PLGA has generated immense interest as a biomaterial due to 
its strong approval history, and its degradation has been studied during the past few 
decades.  PLGA degrades via chemical hydrolysis of the hydrolytically unstable ester 
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bond (Figure 4) into lactic acid and glycolic acid which are non-toxic and biocompatible. 
 The degradation of PLGA is influenced by its Molecular Weight (MW), 
copolymer composition, crystallinity, and other structural characteristics 20.  A 50:50 
copolymer ratio was chosen for these experiments because of its high degradation rate 
and various molecular weights were tested.  However, when this copolymer is implanted 
alone it shows poor regulation on cellular activity, and scaffolds show structural 
instability due to swelling during degradation. 
 
 
Figure 4 Chemical structure of PLGA 
 
Scaffold Fabrication 
 As previously stated controlled rate freezing and lyophilization can be used to 
obtain highly porous and tunable chitosan scaffolds.  In order to incorporate PLGA in the 
chitosan scaffold via this technique both polymers must be present in solution prior o 
freezing. Since PLGA not readily soluble in water, the common method of lyophilization 
could not be applied without some modification.  An emulsion system of organic solvent 
containing PLGA and aqueous solution containing chitosan is tested. In order to stabilize 
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the emulsion a natural emulsifier, 1,2-Dimyristol-sn-Glycero-3-Phosphocholine (DMPC), 





The hypothesis is that by producing a chitosan scaffold with homogenously dispersed 
pockets of PLGA we can take advantage of chitosan’s good cellular activity while 
increasing its degradation rate.  In order to achieve the desired homogenous distribution, 
an emulsion system of an organic solvent containing PLGA in an aqueous solution of 
chitosan stabilized by DMPC was investigated.  The method of controlled rate freezing 
and lyophilization would then be applied to this emulation.  However, the effect of 
introducing these changes on the pore morphology and pore distribution should be 
investigated.  In particular, the method of emulsification, the amount and type of 
stabilizer, the type of organic solvent, and whether the new scaffold is cytotoxic.  Small 
3-D scaffolds were formed using controlled-rate freezing technique and subsequent 
lyophilization.  Using these scaffolds, the relationship between porosity and 
concentration of each polymer were investigated.  The microstructures of these scaffolds 
were analyzed using SEM and digital photo analysis.  A four week long degradation 
study comparing the blended scaffolds and pure chitosan scaffolds in lysozyme solution 
and physiological conditions was conducted.  Results show that a highly porous, 
homogenous scaffold can be obtained and its pore size controlled.  Preliminary results 
show that the scaffolds do not exhibit cytotoxicity and degradation of chitosan has 
increased in the presence of PLGA.  The results of the study may help us evaluate the 




III. MATERIALS AND METHODS 
 
Sources of Chemicals 
50 to 190kD MW chitosan with 85% degree of deacetylation, DMPC (99% from 
egg yolk, 678 Da), and hen egg white (HEW) lysozyme (46,400 U/mg) ,were obtained 
from Sigma Aldrich Chemical Co (St. Louis, MO).  19kD 50:50 PLGA was obtained 
from Alkermes Inc., (Cambridge, MA) while 75kD and 160kD 50:50 PLGA were 
purchased from Birmingham Polymers (Birmingham, AL).  All other reagents were from 
Fisher Scientific (Pittsburgh, PA). 
 
Polymer Solutions 
 0.1 to 1% (wt/volume) chitosan solutions were prepared by dissolution in slightly 
acidic (0.2M acetic acid) solution.  1 to 10% (wt/volume) 50:50 PLGA solutions of 
various MWs were prepared by dissolving in chloroform, methylene chloride, DMSO, or 
benzene.  10% (wt/volume) DMPC solution was prepared in chloroform. 
 
Mixing Ratios 
 Originally equal volume chitosan and PLGA solutions were mixed together; 
however this resulted in partial blending with excess PLGA solution (organic phase) 
separating out.  In order to achieve uniform blending, the amount of PLGA solution was 
gradually decreased until a uniform, white, ad creamy emulsion was present after mixing. 





Method of mixing 
After addition, the samples were capped and mixed by three different methods in 
order to investigate whether the amount of energy used in mixing had an effect on the 
scaffolds. The first method was to simply shake the vials containing the mixture by hand 
for about 20seconds.  The second method was to place the vials on a mini-vortexer 
(Fisher Scientific) at 3200 rpm for 3 to 4 min.  The third method involved sonicatation 
for 90 seconds at 50% amplitude by a 500 Sonic Dismembrator (Fisher Scientific).  
These methods were chosen because each presented a different mechanism for mixing. 
All these samples were used for scaffold formation and their properties analyzed. 
Amount of stabilizer 
Although mixing 3:1 chitosan to PLGA solution resulted in a creamy uniform 
emulsion, it lacked stability after few minutes (depending on the method of mixing) and 
the two phases would separate.  In order to stabilize the emulsion long enough for the 
freezing process to take effect a natural stabilizer 1,2-Dimyristol-sn-Glycero-3-
Phosphocholine (DMPC) was added to the organic phase prior to mixing.  For accuracy 
the DMPC was first dissolved in chloroform (10% wt/volume) and then added volume 
wise to the PLGA solution.  Thru a trial and error method, the minimum amount of 
DMPC solution required for stable emulsion was determined to be 10µL per 1 mL of 





 Unless otherwise stated, blend scaffolds will refer to 3:1 chitosan solution to 
PLGA solution. Chloroform is used as the preferred PLGA solvent and the concentration 
of chitosan and PLGA are 0.3% (wt/v) and 3% (wt/v) respectively in their solutions. 
10µL of 10% DMPC was added for every 1mL of PLGA solution prior to mixing via 
vortexing. 
Formation of scaffolds 
 0.3 to 8 mL portions of the blended emulsions were poured into flat bottomed 15 
mm diameter Nalgen tubes.  Freezing was accomplished by placing these tubes in a large 
(in excess of 1000 X the sample volume) ethanol baths equilibrated at temperatures of -
20°C, -78°C, and liquid nitrogen naturally equilibrating at -196°C in order to achieve 
different cooling rates.  After the samples frozen at -20°C and -78°C equilibrated at their 
respective temperatures, they were subsequently placed in liquid nitrogen prior to 
lyophilization so that all samples the same final temperature.  All samples were 
lyophilized until dry using a Benchtop 6K lyophilizer (VirTis, Gardiner, NY). 
Microstructure characterization 
 Lyophilized scaffolds were sectioned at various planes, attached to sample stubs 
with carbon paint and sputter-coated with palladium prior to examination under a JOEL 
JXM 6400 Scanning Electron Microscope (SEM).  Imaging was conducted at an 
accelerating voltage of 15 kV or 10 kV.  Obtained digital micrographs were analyzed for 
pore area, major axis, minor axis and shape factor using image-analysis software (Sigma 
Scan Pro, SPSS Science, Chicago, IL).  Shape factor is defined as 4 π×area/ perimeter2, 
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and when the number is closer to 1, the cell shape is closer to a circle. See Appendix 1 for 
more details. 
Porosity measurement 
 Total volume was measured by determining the height and the diameter of the 
scaffolds.  The scaffold was then placed inside a graduated cylinder with a pre-measured 
amount of absolute alcohol and the change in the volume of alcohol was measured once 
the scaffold was submerged, which corresponds to the volume of the solids in the 
scaffold. The porosity is thus approximated by: 
( ) 100TotalVolume SolidVolumePorosity
TotalVolume
−
= ×  
 
Macro-environment degradation 
 A 3:1 (aquous:organic) vortexted blend of 1% chitosan solution and 3% 160 kD 
PLGA solution was used to generate 2 mL emulsified scaffolds using chloroform as the 
organic solvent (frozen at -196°C). All of the scaffolds were neutralized and sterilized 
with ethanol prior to further processing.  Half (n=32) of the samples were incubated in 10 
mL of phosphate buffer saline (PBS) solution at 37°C and 5% CO2 /95% air while the 
other half (n=32) were incubated in 10 mL of PBS containing 10 mg/L hen egg white 
(HEW) lysozyme solution and placed in the same conditions.  Chitosan scaffolds without 
PLGA (n=64) were also prepared and used as controls by subjecting them to the same 
conditions as the blended scaffolds.  The initial mass of the scaffolds were recorded and 
the pH of the buffer solution was recorded weekly.  The medium was changed after the 
first week and once every two weeks thereafter.   
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Cellular activity and degradation micro-environment 
 GFP-transfected canine bladder smooth muscle cells (SMC) were a kind gift from 
Dr. Bradley Kropp, Department of Urology, University of Oklahoma Health Science 
Center, Oklahoma City, OK and maintained following his protocol.  The growth medium 
consisted of M199, supplemented with 10% calf serum, 100 U/ml and 100 µg/ml 
penicillin-streptomycin, 2.5 µg/ml amphotericin B, MEM amino acids, 3.56 gm/L 
HEPES, 0.5 gm/L bacteriologic peptone and 1gm/L dextrose.   
 Thin sheets of chitosan and PLGA-chitosan scaffolds were formed by freezing at -
196°C.  They were neutralized and sterilized in alcohol as described for the degradation 
study.  Circular samples covering single wells in a 24-well-culture plate were cut and 
inserted into the wells.  The cell suspension was seeded on these scaffolds at 30,000 
cells/well.  The cells were incubated under 5% CO2 at 37 ºC.  Cultures were fed with 
fresh medium every 48 hours.  Half (n=12) the samples were incubated with media 
containing lysozyme while the other half (n=12) were incubated under similar conditions 
without lysozyme.  Pure chitosan scaffolds were also prepared and used as controls.  
Media was monitored for changes in pH and leached-out GFP-fluorescence.  After one 
and three weeks, scaffolds were dehydrated using ethanol series and analyzed via SEM. 
 
Statistical Analysis 
 The distributions of pore sizes were plotted as box plots to show the 10th, 25th, 
50th, 75th and 90th percentiles and the mean value (thick line within each box).  Values 
that were outside 95th and 5th percentiles were treated as outliers.  At least 50 pores were 
characterized for each condition from micrographs obtained by representative regions of 
 
17 
the scaffolds.  A one-way analysis of variance (ANOVA) with 95% confidence interval 
was also used to evaluate the significant differences between various groups. See 





Obtaining stable emulsions 
 First, the amount of DMPC was optimized based on the minimum amount 
required to stabilize the emulsion for 10 to 30 min. This will allow the freezing process to 
take place while both polymers are uniformly dispersed.  Various quantities of DMPC 
was added to 3:1 solvent ratios of water and organic solvents i.e., chloroform (Figure 
5A), benzene, and methylene chloride.   
no µL 10 µL 20 µL 30 µL 40 µL
 
Figure 5 Stability of emulsions.   
Stability of the emulsion formed by hand mixing 3 mL water and 1 mL chloroform with various 
volumes of DMPC.  Samples with no label contained no PLGA, and no DMPC.  All other samples 
had 3% (wt/v) 19kD PLGA.  Arrow indicates the phase separation region.   
 
Upon mixing of chitosan solution and chloroform as control (Figure 5 vial with 
no label) the solution separates in two phases (arrow).  When PLGA is present but no 
DMPC (Figure 5 vial labeled 0) better mixing occurs yet there is still not uniform 
dispersion especially as time passes.  However when DMPC is added in 10µL, 20µL, 
30µL, and 40µL (vials labeled 1, 2, 3, and 4 respectively) the emulsions are stable up to 
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30 min. No apparent difference could be observed between samples of various DMPC 
contents therefore the smallest amount of DMPC solution (10µL per 1mL PLGA 
solution) was used for all subsequent samples.  
Stability of the emulsion was observed consistently in all the mixtures with 
different polymer contents.  This stability was more prevalent in emulsions formed using 
benzene and chloroform solvents.  Methylene chloride did not reach a stable 
emulsification state.  In samples where stable emulsion was observed, an increase in the 
volume of the organic solvent resulted in organic solvent accumulating on the top or 
bottom of the emulsion, depending on the specific gravity of the organic solvent used 
(Table 1). 
Table 1 Properties of Organic Solvents Used in Dissolving PLGA. 
Organic Solvent Benzene Chloroform Methylene chloride 
Melting Point (°C) 5.5 -63.5 -95.0 
Boiling Point (°C) 80.1 59.0 39.8 
Vapor Pressure (mmHg) 100 at 26.1°C 200 at 25.9°C 400 at 24.1°C 
Specific Gravity(20°C/4°C) 0.879 1.48 1.32 
Heat of Melting(cal/g) 22.64 47.01 12.94 
Specific heat(cal/g. °C) 0.419(6-60°C) 0.232(0°C) 0.288(15-40°C) 
 
However, the observed stability of the emulsion could be due to unknown 
interactions between the three components.  To understand this possibility, global 
changes in the thermal properties were analyzed using a Differential Scanning 
Calorimeter.  These results (data not shown) indicated no significant changes in the 
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structure of three components suggesting no apparent interaction among the components.  
A B
 
Figure 6 Effect of emulsion under SEM.  
Micrograph of a scaffolds in the absence of a stabilizer (Panel A).  Micrograph of a scaffold in 
presence of a stabilizer (Panel B). The scale bars represents 100 µm. 
 
Scaffolds were formed with and without DMPC using controlled rate freezing and 
lyophilization.  Micro architecture analysis using SEM showed globules of PLGA in the 
chitosan network in the scaffolds formed without the emulsifier (Figure 6A).  On the 
other hand, addition of the emulsifier inter-dispersed (Figure 6B) the two components 
uniformly throughout the scaffold with the appearance of homogenous structure along 
with a texture different from pure chitosan scaffolds.  This suggested that the mode of 
stabilization of the emulsion was sufficient to obtain a uniform blendOptimizing chitosan  
 
Optimizing Chitosan concentration for maximum porosity and structural stability 
 Next, to understand the influence of blend compositions, cylindrical scaffolds 
were formed using 0.1% to 1% (wt/volume) chitosan solutions.  Scaffolds formed from 
0.3% chitosan solution showed porosity in the range of 95 to 98%.  A direct relationship 
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between the concentration of chitosan to the porosity of the sample was observed, 
however, the concentrations did not affect the pore morphology.  Increasing PLGA 
content from 2% to 6% (wt/volume) at a constant chitosan content of 0.3% (wt/volume), 
moderately decreased the porosity to 92-93%.  Quantification of scanning electron 
micrographs showed that addition of PLGA to chitosan did not significantly affect the 
pore size distribution and the shape of the pores in the scaffolds (Figure 7). However, 
scaffolds formed with PLGA alone from the emulsions showed decreased pore area and 
diameter due to structural collapse.  Based on these results, subsequent scaffolds used 






























Figure 7 Scaffolds of chitosan-PLGA Blends. 
Box plot showing the distribution of pore area (Panel A) and the shape factor (Panel B) of the pores 
in the scaffolds. 
 
Method of emulsification 
 Since the method of combining PLGA with chitosan could determine the 
distribution of two phases, the method of mixing by sonication, vortexing and hand 
mixing were compared.  These results showed that sonication for 90 sec alone produced 
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emulsions of the two components in the absence of the stabilizer although these 
emulsions showed phase separation within 10 min of the process.  Nevertheless, adding 
the stabilizer to the emulsion significantly extended the stability.  Next, these emulsions 
were frozen at an ethanol bath maintained at -78°C and then lyophilized to obtain porous 
scaffolds.  These results showed that emulsions formed after all the three mixing methods 
generated structurally stable scaffolds.  Analysis of the scaffolds via SEM showed no 
significant difference between the methods of mixing i.e., sonication (Figure 8A), 
vortexing (Figure 8B), and hand mixing (data not shown) on the micro-architecture of 




Figure 8 Method of mixing doesn’t influence scaffold properties. 
Micrographs of scaffolds formed using 3% of 160 kD at -78°C after sonication (Panel A) and after 
vortexing (Panel B) were characterized for pore sizes (Panel C) and shape factor (Panel D). 
 
Further quantification of the micrographs showed (Figure 8C and 8D) no significant 
difference in pore area, pore diameter or the shape factor of these scaffolds.  Thus 
vortexing was used in all the subsequent studies. 
 
Effect of freezing rate on pore size and morphology 
 To better understand the influence of rate of freezing on microarchitecture of the 
blend scaffolds, samples were frozen and at various cooling rates. This was achieved by 
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constant temperature ethanol bath maintained at -20°C and -78°C or liquid nitrogen baths 
of -196°C.  These results showed that controlled rate freezing easily regulated the pore 
size distribution between 2 µm and 300 µm (Figure 9A and 9B), similar to pure chitosan 
scaffolds. 
 
Figure 9 Rate of cooling influences pore morphology. 
Scaffolds were characterized for pore size (Panel A) and shape factor (Panel B).  Micrographs of 
scaffolds formed using 3% of 19kD after freezing at -20°C (Panel C) and -196°C (Panel D). 
 
The lower heat transfer rate of -20°C ethanol bath produced much larger pore 
sizes relative to samples frozen at the higher heat transfer rate present in the -78°C 
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ethanol baths.  However, a careful observation of the scaffolds showed moderate phase 
separation and formation of globules in samples frozen at -20°C (Figure 9C).  This could 
be attributed to the physical characteristics of chloroform such as the melting point 
(shown in Table 1); when frozen at -20°C, due to a) preferential cooling of water, b) 
reduced freezing rate, and c) no solidification of chloroform, resulted in phase separation.  
Nevertheless, due to subsequent cooling of samples at -196°C resulted in crystallization 
of chloroform and formation of micro pores within the globules (see the inset picture in 
Figure 9C).  Similar characteristics were also more prevalent in methylene chloride 
containing samples frozen at -20°C or -78°C.  On the contrary, this was not observed in 
samples frozen directly at -196°C (Figure 9D) or benzene containing samples.  Further, 
when benzene was used as the organic solvent, freezing the samples at -20°C did not 
show any phase separation due to the high melting point of benzene (Table 1). 
 
Comparison of effect of organic solvent on the pore size and shape 
 Since the effect of rate of cooling was confounded by the physical properties of 
the organic solvents, influence of organic solvents alone on scaffold pore morphology 
was studied by freezing 1% 19kD PLGA dissolved in benzene, chloroform, or methylene 
chloride, and 0.3% chitosan at a constant temperature of -196°C.  The lower amount of 
50:50 PLGA was set by the limited solubility <1.5% (wt/volume) in benzene.  These 
results showed that freezing samples at -196°C produced relatively large pore sizes in 
scaffolds formed using chloroform (Figure 10A) and methylene chloride (data not 
shown) rather than benzene (Figure 10B) as the solvent.  The addition of organic 
solvents further increased the pore areas (Figure 10C) than scaffolds formed with pure 
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water alone 12. 
 
Figure 10 Effect of organic solvent on the pore morphology. 
Micrographs of scaffolds formed after freezing at -196°C using 1.5% of 19kD in chloroform (Panel 
A), and benzene (Panel B) were characterized for pore size (Panel C) and shape factor (Panel D). 
 
 There was no significant difference in the shape of the porous structure in all the 
organic solvents and the average of shape factor varied from 0.75 to 0.8 (Figure 10D).  
Previous research has shown that dimethyl sulfoxide (DMSO) can be used to combine 
PGA (polyglycolide) and chitosan utilizing a freeze drying process 21.  However we were 
not able to produce larger scaffolds than the reported 500µm thick samples.  This is due 
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to the low vapor pressure of DMSO which makes it difficult to fully remove the solvent 
in a lyophilizer at room temperature unless the scaffold is thin and flat.  Limitations in 
emulsifying methylene chloride, reduced solubility of 50:50 PLGA in benzene, and 
difficulties in lyophilizing DMSO, led to choosing chloroform as the organic solvent in 
subsequent experiments.   
 
Effect of MW of PLGA on pore size and morphology 
 To understand how the MW of PLGA influences the pore morphology, 3% 19kD, 
75kD and 160 kD PLGA were blended with 0.3% chitosan.  Although a change in the 
viscosity of the PLGA solution was noticeable, no significant differences were observed 
during emulsification process.  To understand the influence on scaffold architecture, 
samples were frozen at -78°C (Figure 11A and 11B) or at -196°C and then lyophilized. 
 These results showed that the increase in MW of PLGA decreased the pore sizes 
of the scaffold (Figure 11C) but the pore shapes were not affected (Figure 11D).  The 
decrease was more significant in samples frozen at -78°C than at -196°C; when samples 
were frozen at -196°C only a trend towards decreased pore sizes with no significant 





Figure 11 Increased MW of PLGA may decrease pore size. 
Increased MW of PLGA may decrease pore size.  Micrographs of scaffolds formed after freezing at -
78°C using 3% of 75 kD (Panel A), and 160 kD (Panel B) PLGA were characterized for pore sizes 






Effect of PLGA on Chitosan degradation 
 To test the hypothesis that introducing PLGA enhances the degradation of 
chitosan, cylindrical scaffolds formed using chloroform were incubated in 10 mL of PBS 
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containing 10 mg/L lysozyme.  The concentration of lysozyme was chosen to mimic the 
physiological circulating levels in the plasma which is 4-13 mg/L 22.  Results (Figure 
12A) show that only chitosan/PLGA scaffolds incubated in the presence of lysozyme 
structurally collapsed by week four.   
 
Figure 12 Degradation characteristics of chitosan/PLGA scaffolds. 
Panel A.  Photographs taken after 24 days i) chitosan in PBS, ii) chitosan-PLGA PBS, iii) chitosan in 






All other samples did not show significant alterations in the dimensional changes unlike 
pure PLGA scaffolds which show swelling during degradation 23.  To understand the 
reason, media pH was monitored.  These results (Figure 12B) indicated that 
chitosan/PLGA scaffolds incubated in presence of lysozyme showed a significant 
reduction in pH relative to all other conditions, probably due to the synergistic 
degradation of both chitosan and PLGA which form acidic products.  This drop in pH 
increases the activity of lysozyme in addition to the possibility of dissolving chitosan. 
 
Effect of PLGA on cell spreading 
 The increased degradation with drop in pH of the macroenvironment cannot be 
expected in vivo because the acid will be readily cleared.  In addition, altered pH could be 
cytotoxic to cell survival.  Therefore cellular activity and the degradation characteristics 
of the scaffolds under conditions where the global pH of the solution is held constant via 
frequent buffer changes were studied.  When SMCs were cultured, the measured 
fluorescence of the media showed no significant increase in the GFP-fluorescence 
relative to control or chitosan, suggesting no toxicity.  However, when cell spreading was 
compared (Figure 13), cells on PLGA-chitosan showed reduction in cell spreading area 




Figure 13 Spreading characteristics of SMC. 
GFP-transfected canine bladder smooth muscle cells seeded on lyophilized scaffolds at 30,000 
cells/well.  Panel A.  Photographs showing thin scaffolds.  Panel B.  Chitosan scaffold.  Panel C.  160 
kD emulsified PLGA/chitosan scaffold. 
 
Analysis of the degradation characteristics showed an increase in the amount of 
chitosan degradated in the presence of PLGA as compared to pure scaffolds.  Day zero 
SEM micrographs of pure chitosan scaffolds (Figure 14A) showed a porous structure 
underneath the skin layer. Blend scaffold (Figure 14D) showed a similar structure but 
with more porous skin layer.  After one week, without the presence of lysozyme, chitosan 
and blend scaffolds (Figure 14B and 14E) showed negligible degradation of the top 
layer.  However, in the presence of lysozyme, the blend scaffolds (Figure 14F) show 
significant decrease in the skin layer than pure chitosan scaffolds (Figure 14C).  
Chitosan scaffolds did not show significant degradation in the presence of lysozyme even 
after three weeks (data not shown) and was similar to week one samples.  However, the 
blend scaffolds after 3 weeks (Figure 14G and 14H) show significant degradation of the 




Figure 14 Degradation Characteristics of blend and chitosan scaffolds at constant pH. 
SEM micrographs of lyophilized scaffolds. Panel A.  Day 0 Chitosan.  Panel B.  Week 1 chitosan with 
no lysozyme.  Panel C.  Week 1 chitosan with lysozyme.  Panel D. day 0 blend.  Panel E. week 1 blend 
without lysozyme.  Panel F.  Week 1 blend with lysozyme.  Panel G.  Week 3 blend without lysozyme.  
Panel H.  Week 3 blend with lysozyme. 
 
The media was changed on a daily basis and the pH of the removed media was 
measured. Results show no significant change in pH in all the samples, indicating a 
constant pH.  Studying the increased deterioration of the skin effect in the blend scaffold 
as opposed to pure chitosan scaffolds shows that the presence of PLGA can potentially 




Effect of PLGA on scaffold integrity 
 It was believed that by introducing PLGA into the chitosan scaffold would result 
in a mechanically stronger scaffold than chitosan alone because PLGA is stronger than 
chitosan.  This was not the case as the emulsified blend scaffolds were weaker than pure 
chitosan.  In order to take advantage of PLGA’s stronger mechanically properties it must 
be connected throughout the scaffold.  To achieve such structure an alternate fabrication 
technique is proposed for future study.  This technique suggests first forming a layer of 
PLGA film via evaporation then freeze drying a thin aqueous layer containing chitosan 
on top.  SEM micrographs of such scaffolds show an open pore structure on the surface 
(Figure 15A and 15D) and a smooth continuous PLGA film on the bottom  (Figure 15B 
and 15C).  This structure allows PLGA to provide the backbone for the scaffold while 
the chitosan is responsible for cell interaction; at the same time due to the proximity of 
the two polymers the same enhance degradation characteristics from emulsified scaffolds 
can be expected. The mechanical properties of this scaffold depend on the thickness of 




Figure 15 SEM micrographs of porous chitosan atop of a PLGA film. 





This study evaluated the blending of chitosan with 50:50 PLGA in the 
emulsification mode using DMPC as the stabilizer.  An emulsion system was used to 
homogenously disperse PLGA within the chitosan scaffold.  This was done to prevent 
chemical changes to chitosan which might affect its desirable properties such as cell 
attachment and survival. Highly porous three dimensional scaffolds were obtained with 
no apparent chemical interaction between chitosan and PLGA.  From visual observation, 
it was evident that the PLGA solution was dispersed in the form of micelles in the 
aqueous phase.  This notion was further confirmed from the general structure of the 
scaffolds under SEM which resembled chitosan scaffolds in their overall 
microarchitecture.  In the presence of DMPC, emulsions were stable for long enough 
time that was sufficient for the freezing process to take place.  
 Analysis of the prepared scaffolds showed that the freezing temperature 
influenced pore size, similar to pure chitosan scaffolds 12, but MW of PLGA as well as 
the type of organic solvent also influenced the pore morphology.  Of the three organic 
solvents used, benzene and chloroform emulsions were more stable than methylene 
chloride.  Other organic solvents with sufficient synthetic polymer solubility can also be 
used, if necessary.  However, the solvent should have high enough vapor pressure at 
room temperature (Table 1) to allow complete lyophilization.  Reduction in chitosan 
concentration resulted in increased porosity up to 95%, however, scaffolds showed 
structural instability at very low (0.3%) chitosan concentrations.  Blending PLGA with 
chitosan resulted in highly porous scaffolds.  This system is not exclusive to chitosan and 
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PLGA combination alone and can be used for any two biopolymers where the solvents 
are aqueous and organic. 
 The degradation results showed that chitosan scaffolds containing PLGA have an 
enhanced lysozymal degradation rate.  This effect can be attributed to the acidic 
environment created by release of lactic and glycolic acids during the degradation of 
PLGA.  Further results show that this increase in degradation is still evident even if the 
global pH of the scaffold is held constant indicating that the local pH changes are 
responsible for enhanced degradation effect resulting in open pore morphology.  Previous 
research has shown that lysozyme is much more active in acidic conditions than neutral, 
which this degradation study confirms.  
 Cellular activity of SMCs on these scaffolds showed no cytotoxic effects.  
However, a reduction in cell spreading area suggests a possible reduction in cell 
colonization.  In a separate study, cell adhesion, cell proliferation, alteration in the 
cytoskeletal organization of endothelial cells and fibroblasts were studied and the fate of 
DMPC have been extensively studied 24.  These results show a reduction in cell 
proliferation and the internalization of DMPC.  This suggests a need for improving the 
cellular activity by blending cytoadhesive polymers such as fibronectin or collagen into 
these scaffolds.  Furthermore, preliminary mechanical property analysis indicates a 
reduction in the break stress and strain values relative to chitosan 25 and needs detailed 
analysis.  An alternative fabrication technique is proposed in order to take advantage of 
PLGA’s superior mechanical properties. 
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VI. CONCLUSIONS AND RECOMMENDATIONS 
 
 In summary, this study demonstrated that chitosan and PLGA can be blended to 
obtain uniform, porous, 3-D scaffolds. These scaffold exhibits faster degradation than 
pure chitosan scaffolds.  Using 3:1 ratio (volume/volume) of chitosan solution to PLGA 
solution (chloroform) and freezing in a -196°C bath showed better characteristics in the 
pore size, homogeneity of scaffold, ease of processing, degradation, and cell culture.  
Future studies investigating the detailed degradation kinetics of chitosan in the presence 
of PLGA needs to be conducted as well as investigating the thermodynamics of the 
freezing process.  Also of interest is whether the blended scaffolds containing PLGA 
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APPENDIX I:  EVALUATION OF PORE CHARACTERISTICS 
 
Step 1:  Obtain digital image via Scanning Electron Microscope (SEM) 
 
Step 2:  Open image in Sigma Scan Pro 
 







Step 4:  Go to Measurements Settings and select Area, Major axis, Minor Axis, and 
Shape Factor. 
 
Step 5:  Go to Mode and select Trace Measurement Mode. Use the curser to highlight 








APPENDIX II:  SAMPLE RAW DATA 
 





Length(micrometers) Shape Factor 
Sonicated Vortexed Sonicated Vortexed Sonicated Vortexed Sonicated Vortexed 
4235.511 1280.618 95.2611 59.71716 70.39434 27.88959 0.679109 0.721117
1303.67 489.1277 45.2975 34.6405 39.92696 17.64466 0.874892 0.741195
2032.025 487.4223 66.76814 33.16277 37.83124 21.92139 0.795922 0.723012
3736.715 369.8525 90.75908 23.63713 49.71222 21.13875 0.764713 0.849083
881.3944 388.7191 35.71176 23.882 32.05228 23.29151 0.88303 0.848553
894.1477 313.0219 35.88987 22.26514 34.8482 21.04146 0.866889 0.651031
732.6059 311.2453 37.83124 29.92411 33.20318 14.77612 0.660811 0.698939
724.1037 367.8629 34.60336 28.63912 26.61797 17.70497 0.890627 0.782442
498.7955 648.7476 29.7598 32.26842 22.89764 28.49515 0.805958 0.810051
1136.46 339.9005 49.08111 24.56081 32.16262 17.28097 0.735551 0.833448
610.7411 481.542 35.01047 29.9514 24.27932 23.10619 0.677706 0.792953
569.6472 403.6952 30.1148 31.77521 27.14511 18.67764 0.821318 0.733577
1149.214 1574.436 44.173 54.72715 33.85823 36.58183 0.783045 0.790891
                
1493.553 2130.783 59.10149 70.88661 30.1148 42.18245 0.729872 0.749342
1582.826 2851.423 49.03779 72.30939 43.89948 48.69288 0.855059 0.812125
2474.139 2823.843 99.45295 70.38911 35.5128 54.5199 0.559521 0.818168
1309.338 2548.043 72.31079 73.06824 22.99029 44.61181 0.490348 0.800278
1190.307 5959.075 42.92019 107.908 39.57046 74.89613 0.85745 0.765442
1799.632 1359.431 74.01519 57.91453 31.44978 28.87265 0.64386 0.712466
980.5867 1681.495 38.75635 62.96358 35.79103 32.56529 0.809589 0.766524
1480.799 1510.676 58.62 54.06106 30.90437 38.15123 0.605259 0.7988
3723.962 1411.922 97.1173 49.49028 57.4603 37.08699 0.613746 0.831665
2393.368 1564.947 67.02234 58.57137 48.63155 33.86439 0.784651 0.778442
1402.862 2009.786 54.52462 56.60942 32.38216 46.44861 0.719466 0.852225
1912.994 1732.206 62.85449 64.80878 42.06987 36.78591 0.807397 0.780119
742.5252 2108.541 33.83729 61.44754 26.75073 43.84744 0.855352 0.853938
2039.11 800.9555 66.76814 35.32483 36.67102 32.26549 0.773969 0.848838
3524.16 613.5039 100.1982 31.45691 48.97996 23.95232 0.60448 0.847381
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APPENDIX III:  BOX PLOTS 
 
The box plot is a graphic display of the data that shows set’s lowest value, highest value, 
median value and the size of the first and third quartile range.  It is a quick method for 
determining the basic shape of a distribution and is also useful in detecting outliers.  
These plots originate from the work of Tukey (1977). 
The Five Number Summary Box Plot.  
 
Variations on the box-plot Sometimes the whiskers on the box-plot have a different 
methods of constructions, however, the hinges are always computed as the 25th, 50th, and 
75th percentiles.  
outliers may be identified using an outlier detection rule and are displayed using asterisks 
or some other character.  
whiskers extend to 10th and 90th percentiles;  










the thick line corresponds to the mean.  
median is the thin in the box 
it is easy to compare groups by constructing side-by-side box plots as shown below.  
 
q25 = lower quartile, 25%of the data lie below this value  
 
q50 = median, 50%of the data lie below this value  
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